Search Details

Word: tests (lookup in dictionary) (lookup stats)
Dates: during 2000-2009
Sort By: most recent first (reverse)


Usage:

Last month, investigators in the U.S. reported good test results for a monthly dose of the common antidrinking drug naltrexone - a medication that currently must be taken every day to be effective. But naltrexone is controversial because for some, it doesn't do anything to reduce the craving for alcohol until those addicts actually take a drink, whereupon it helps them resist taking more - a twisted bit of physiological irony if ever there was one. Twelve-step believers say the only proper response to alcoholism is total abstinence, and that a drug that allows you to drink a little puts...

Author: /time Magazine | Title: Battling Addiction: Are 12 Steps Too Many? | 1/27/2009 | See Source »

...change. There is now a quick and reliable way to check the viability of eggs before fertilization and implantation begin - and two months from now, a previously childless 41-year-old woman will give birth to the baby who proves it. (Read TIME's 1978 article, "The First Test-Tube Baby...

Author: /time Magazine | Title: Building a Better Baby: A New In Vitro Test | 1/27/2009 | See Source »

...TIME's 1978 cover "The Test-Tube Baby...

Author: /time Magazine | Title: Building a Better Baby: A New In Vitro Test | 1/27/2009 | See Source »

...trial, which will test a stem-cell-based treatment for spinal-cord injury, will begin later this summer and will use cells generated by Geron Corp. The approval marks the first time human stem cells, extracted and grown from embryos, will be transplanted into patients. Adult stem cells, which are present in many types of tissue, have been used in treatments for years - the most common being bone-marrow transplants in cancer care - but an embryonic study is a whole new thing. There's a good reason it's being greeted with so much excitement. (See the top 10 medical...

Author: /time Magazine | Title: Cautious Optimism for the First Stem-Cell Human Trial | 1/24/2009 | See Source »

...Because no one has used embryonic stem cells or the cells derived from them in people before, the FDA was particularly cautious. The trial that it approved is what's known as a Phase 1. It will involve no more than a dozen patients and is not designed to test the effectiveness of the cells. Rather, it will simply monitor the safety of inserting them into people. The researchers will be looking for whether the cells cause tumors, trigger an immune response or start to migrate away from the spinal-cord area. "There are certainly unknowns that...

Author: /time Magazine | Title: Cautious Optimism for the First Stem-Cell Human Trial | 1/24/2009 | See Source »

Previous | 159 | 160 | 161 | 162 | 163 | 164 | 165 | 166 | 167 | 168 | 169 | 170 | 171 | 172 | 173 | 174 | 175 | 176 | 177 | 178 | 179 | Next